Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
501 AZD2796, a myeloid checkpoint inhibitor targeting LILRB2 that promotes pro-inflammatory responses by macrophages and enhances T cell anti-tumor activity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 501 AZD2796, a myeloid checkpoint inhibitor targeting LILRB2 that promotes pro-inflammatory responses by macrophages and enhances T cell anti-tumor activity